Clal Insurance Enterprises Holdings LTD Keros Therapeutics, Inc. Transaction History

Clal Insurance Enterprises Holdings LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$26.03 - $67.04 $546,630 - $1.41 Million	-21,000 Reduced 6.56%	299,000 $8.26 Million
Q4 2021 Feb 10, 2022	BUY	$36.95 - $62.89 $327,561 - $557,519	8,865 Added 2.85%	320,000 $18.7 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $259,478 - $387,489	-8,865 Reduced 2.77%	311,135 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $11.5 Million - $26.5 Million	320,000 New	320,000 $21.1 Million

177

30.1M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $294M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.